Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome

Brain

Volumn 135, Issue 6, 2012, Pages 1926-1936

  Lerner, Alicja ^a   Bagic, Anto ^b   Simmons, Janine M ^c   Mari, Zoltan ^d   Bonne, Omer ^e   Xu, Ben ^f   Kazuba, Diane ^c   Herscovitch, Peter ^g   Carson, Richard E ^h   Murphy, Dennis L ^c   Drevets, Wayne C ⁱ   Hallett, Mark ^f  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ University of Oklahoma Tulsa College of Medicine   (United States)

Author keywords

flumazenil; PET; tics; Tourette syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL C 11;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; FEMALE; GILLES DE LA TOURETTE SYNDROME; GLOBUS PALLIDUS; HUMAN; INSULA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIAQUEDUCTAL GRAY MATTER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; THALAMUS;

EID: 84861559469     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws104     Document Type: Article

References (86)

1. Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003; 61: 310-5.
2. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
3. Anderson S, Mione M, Yun K, Rubenstein JL. Differential origins of neocortical projection and local circuit neurons: role of Dlx genes in neocortical interneuronogenesis. Cereb Cortex 1999; 9: 646-54.
4. Andersson JL, Vagnhammar BE, Schneider H. Accurate attenuation correction despite movement during PET imaging. J Nucl Med 1995; 36: 670-8.
5. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999; 7: 254-66.
6. Atmaca M, Yildirim H, Ozdemir H, Ozler S, Kara B, Ozler Z, et al. Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1283-6.
7. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, et al. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998; 50: 291-313.
8. Baym CL, Corbett BA, Wright SB, Bunge SA. Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain 2008a; 131: 165-79.
9. Baym CL, Corbett BA, Wright SB, Bunge SA. Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain 2008b; 131: 165-79.
10. Benarroch EE. GABAA receptor heterogeneity, function, and implications for epilepsy. Neurology 2007; 68: 612-614.
11. Bentue-Ferrer D, Bureau M, Patat A, Allain H. Flumazenil. CNS Drug Reviews 1996; 2: 390-414.
12. Biswal B, Ulmer JL, Krippendorf RL, Harsch HH, Daniels DL, Hyde JS, et al. Abnormal cerebral activation associated with a motor task in Tourette syndrome. AJNR Am J Neuroradiol 1998; 19: 1509-12.
13. Bohlhalter S, Goldfine A, Matteson S, Garraux G, Hanakawa T, Kansaku K, et al. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006; 129: 2029-37.
14. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, et al. The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993; 9: 277-91.
15. Breiter HC, Rauch SL. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 1996; 4: S127-38.
16. Butler IJ, Koslow SH, Seifert WE Jr, Caprioli RM, Singer HS. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979; 6: 37-9.
17. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3: 655-66.
18. Craig AD. Forebrain emotional asymmetry: a neuroanatomical basis? Trends Cogn Sci 2005; 9: 566-71.
19. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992; 15: 353-75.
20. Dennis T, Dubois A, Benavides J, Scatton B. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J Pharmacol Exp Ther 1988; 247: 309-22.
21. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol 1983; 40: 508-14.
22. Di Cristo G. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin Genet 2007; 72: 1-8.
23. Dresel C, Castrop F, Haslinger B, Wohlschlaeger AM, Hennenlotter A, Ceballos-Baumann AO. The functional neuroanatomy of coordinated orofacial movements: sparse sampling fMRI of whistling. Neuroimage 2005; 28: 588-97.
24. Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM. High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 1999; 38: 86-94.
25. Fedi M, Berkovic SF, Macdonell RA, Curatolo JM, Marini C, Reutens DC. Intracortical hyperexcitability in humans with a GABAA receptor mutation. Cereb Cortex 2008; 18: 664-9.
26. Ferreira PE, Palmini A, Bau CH, Grevet EH, Hoefel JR, Rohde LA, et al. Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm 2009; 116: 623-9.
27. Frankle WG, Cho RY, Narendran R, Mason NS, Vora S, Litschge M, et al. Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology 2009; 34: 624-33.
28. Galanopoulou AS. Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res 2008; 80: 99-113.
29. Garraux G, Goldfine A, Bohlhalter S, Lerner A, Hanakawa T, Hallett M. Increased midbrain gray matter in Tourette's syndrome. Ann Neurol 2006; 59: 381-5.
30. Gilbert DL, Christian BT, Gelfand MJ, Shi B, Mantil J, Sallee FR. Altered mesolimbocortical and thalamic dopamine in Tourette syndrome. Neurology 2006; 67: 1695-7.
31. Haber SN, Kowall NW, Vonsattel JP, Bird ED, Richardson EP Jr. Gilles de la Tourette's syndrome. A postmortem neuropathological and immu-nohistochemical study. J Neurol Sci 1986; 75: 225-41.
32. Hoshi E, Tremblay L, Feger J, Carras PL, Strick PL. The cerebellum communicates with the basal ganglia. Nat Neurosci 2005; 8: 1491-3.
33. Huang ZJ, Di CG, Ango F. Development of GABA innervation in the cerebral and cerebellar cortices. Nat Rev Neurosci 2007; 8: 673-86.
34. Jansen A, Floel A, Van RJ, Konrad C, Rotte M, Forster AF, et al. Crossed cerebro-cerebellar language dominance. Hum Brain Mapp 2005; 24: 165-72.
35. Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci USA 2005; 102: 13307-12.
36. Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010; 518: 277-91.
37. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995; 18: 527-35.
38. Kultas-Ilinsky K, Leontiev V, Whiting PJ. Expression of 10 GABA(A) receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry. Neuroscience 1998; 85: 179-204.
39. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28: 566-73.
40. Leckman JF, Scahill L. Possible exacerbation of tics by androgenic steroids. N Engl J Med 1990; 322: 1674.
41. Lee JS, Yoo SS, Cho SY, Ock SM, Lim MK, Panych LP. Abnormal thal-amic volume in treatment-naive boys with Tourette syndrome. Acta Psychiatr Scand 2006; 113: 64-7.
42. Lerner A, Bagic A, Boudreau EA, Hanakawa T, Pagan F, Mari Z, et al. Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 2007; 68: 1979-87.
43. Lerner A, Bagic A, Hanakawa T, Boudreau EA, Pagan F, Mari Z, et al. Involvement of insula and cingulate cortices in control and suppression of natural urges. Cereb Cortex 2009; 19: 218-23.
44. Maciunas RJ, Maddux BN, Riley DE, Whitney CM, Schoenberg MR, Ogrocki PJ, et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J Neurosurg 2007; 107: 1004-14.
45. Marin O, Anderson SA, Rubenstein JL. Origin and molecular specification of striatal interneurons. J Neurosci 2000; 20: 6063-76.
46. Millet P, Graf C, Buck A, Walder B, Ibanez V. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters. Neuroimage 2002; 17: 928-42.
47. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997; 49: 410-5.
48. Muller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, et al. Dopamine D2 receptor imaging in Gilles de la Tourette syndrome. Acta Neurol Scand 2000; 101: 165-71.
49. Noebels JL. The biology of epilepsy genes. Annu Rev Neurosci 2003; 26: 599-625.
50. Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, et al. [18F]flumazenil binding to central benzodiazepine receptor studies by PET-quantitative analysis and comparisons with [11C]flumazenil. Neuroimage 2009; 45: 891-902.
51. Orth M, Amann B, Robertson MM, Rothwell JC. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 2005; 128: 1292-300.
52. Paladini CA, Celada P, Tepper JM. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience 1999; 89: 799-812.
53. Peterson BS, Choi HA, Hao X, Amat JA, Zhu H, Whiteman R, et al. Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 2007; 64: 1281-91.
54. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, et al. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992; 17: 553-63.
55. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998; 55: 326-33.
56. Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, et al. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003; 60: 415-24.
57. Pleasure SJ, Anderson S, Hevner R, Bagri A, Marin O, Lowenstein DH, et al. Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron 2000; 28: 727-40.
58. Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA, et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006; 63: 795-807.
59. Plessen KJ, Wentzel-Larsen T, Hugdahl K, Feineigle P, Klein J, Staib LH, et al. Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry 2004; 161: 2028-37.
60. Porta M, Brambilla A, Cavanna AE, Servello D, Sassi M, Rickards H, et al. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. Neurology 2009; 73: 1375-80.
61. Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367-78.
62. Schmahmann JD, Doyon J, McDonald D, Holmes C, Lavoie K, Hurwitz AS, et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage 1999; 10: 233-60.
63. Schultz RT, Carter AS, Gladstone M, Scahill L, Leckman JF, Peterson BS, et al. Visual-motor integration functioning in children with Tourette syndrome. Neuropsychology 1998; 12: 134-45.
64. Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2002; 2: 795-816.
65. Singer HS, Butler IJ, Tune LE, Seifert WE Jr, Coyle JT. Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol 1982; 12: 361-6.
66. Singer HS, Wong DF, Brown JE, Brandt J, Krafft L, Shaya E, et al. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome. Adv Neurol 1992; 58: 233-9.
67. Smith AM, Bruckbauer T, Wienhard K, Pietrzyk U, Byars LG. Spatial transformation during 3D reconstruction in positron emission tomography. Eur J Nucl Med 1997; 24: 1413-7.
68. Stern ER, Blair C, Peterson BS. Inhibitory deficits in Tourette's syndrome. Dev Psychobiol 2008; 50: 9-18.
69. Stern E, Silbersweig DA, Chee KY, Holmes A, Robertson MM, Trimble M, et al. A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000; 57: 741-8.
70. Stoetter B, Braun AR, Randolph C, Gernert J, Carson RE, Herscovitch P, et al. Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET. Adv Neurol 1992; 58: 213-26.
71. Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010; 46: 831-44.
72. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999; 56: 913-9.
73. Takayama C. GABAergic signaling in the developing cerebellum. Int Rev Neurobiol 2005; 71: 63-94.
74. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, Inc.; 1988.
75. Tobe RH, Bansal R, Xu D, Hao X, Liu J, Sanchez J, et al. Cerebellar morphology in Tourette syndrome and obsessive-compulsive disorder. Ann Neurol 2010; 67: 479-87.
76. Turjanski N, Sawle GV, Playford ED, Weeks R, Lammerstma AA, Lees AJ, et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry 1994; 57: 688-92.
77. Veliskova J, Moshe SL. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 2001; 50: 596-601.
78. Visser-Vandewalle V, Temel Y, Boon P, Vreeling F, Colle H, Hoogland G, et al. Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003; 99: 1094-100.
79. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM. Putting a spin on the dorsal-ventral divide of the stri-atum. Trends Neurosci 2004; 27: 468-74.
80. Weeks RA, Turjanski N, Brooks DJ. Tourette's syndrome: a disorder of cingulate and orbitofrontal function? QJM 1996; 89: 401-8.
81. Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol 2008; 65: 952-7.
82. Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neuro-chemistry study with PET. Neuropsychopharmacology 2008; 33: 1239-51.
83. Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997; 38: 1243-7.
84. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 2002; 22: 1440-52.
85. Zezula J, Cortes R, Probst A, Palacios JM. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988; 25: 771-95.
86. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997; 154: 1277-84.